{"protocolSection":{"identificationModule":{"nctId":"NCT06473675","orgStudyIdInfo":{"id":"2024-01"},"organization":{"fullName":"Distalmotion SA","class":"INDUSTRY"},"briefTitle":"Hysterectomy With Adnexal Surgery Procedures With the DEXTER Robotic System (The HYPER Study)","officialTitle":"Hysterectomy With Adnexal Surgery Procedures With the DEXTER Robotic System"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-06","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2024-11","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-12","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-19","studyFirstSubmitQcDate":"2024-06-19","studyFirstPostDateStruct":{"date":"2024-06-25","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-06-19","lastUpdatePostDateStruct":{"date":"2024-06-25","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Distalmotion SA","class":"INDUSTRY"},"collaborators":[{"name":"confinis AG","class":"UNKNOWN"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing robotic-assisted and laparoscopic hysterectomy with adnexal surgery for benign disease."},"conditionsModule":{"conditions":["Hysterectomy"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"CASE_ONLY","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":50,"type":"ESTIMATED"}},"armsInterventionsModule":{"interventions":[{"type":"PROCEDURE","name":"Hysterectomy with adnexal surgery","description":"Robotic-assisted and laparoscopic hysterectomy with adnexal surgery for benign disease."}]},"outcomesModule":{"primaryOutcomes":[{"measure":"primary safety endpoint","description":"occurrence of Clavien - Dindo grades III-V adverse events","timeFrame":"up to 42 days"},{"measure":"primary performance endpoint","description":"successful completion of the Dexter-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach","timeFrame":"intraoperative"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Aged \\> 18 years\n* Patients planned to undergo elective robot-assisted and laparoscopic hysterectomy with adnexal surgery for benign disease; using one camera port, two ports for the manipulating instruments, and additional ports as needed.\n\nExclusion Criteria:\n\n* Morbidly obese patients (BMI \\> 40)\n* Any relative and absolute contraindications for the use of conventional endoscopes and endoscopic surgical instruments\n* Need for robotic stapling, advanced energy delivery, ultrasound, cryoablation and microwave energy delivery\n* Bleeding diathesis\n* Pregnancy\n* Patients with pacemakers or internal defibrillators\n* Any planned concomitant procedures\n* Patient deprived of liberty by administrative or judicial decision.\n* Participation in another interventional clinical trial","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Adult patients undergoing a hysterectomy with adnexal surgery for benign disease.","samplingMethod":"NON_PROBABILITY_SAMPLE"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"}},"hasResults":false}